Czepczyński Rafał, Wyszomirska Anna, Gryczyńska Maria, Szczepanek-Parulska Ewelina, Ruchała Marek
Department of Endocrinology, Metabolism and Internal Medicine Poznan University of Medical Sciences.
Endokrynol Pol. 2018;69(1):24-27. doi: 10.5603/EP.a2018.0009. Epub 2018 Jan 10.
Distant metastases of papillary thyroid carcinoma (PTC) may lack the ability to concentrate radioiodine. In such cases, positive somatostatin receptor scintigraphy might be useful in demonstrating the expression of somatostatin receptors that are potential therapeutic targets. To date, only a few cerebellar metastases from PTC have been reported in the literature.
We present an 82-year-old female, in whom an asymptomatic cerebellar metastasis from PTC was diagnosed by means of Tc-99m-EDDA/HYNIC-TOC scintigraphy four years after the initial diagnosis. She was previously treated with total thyroidectomy and regional lymph node dissection, followed by three cycles of radioiodine therapy. Despite persistently elevated thyroglobulin, no specific radioiodine accumulation was found in the whole body post-treatment scan. Tc-99m-EDDA/HYNIC-TOC scintiscan revealed foci of increased tracer uptake in the lungs, cervical lymph nodes, and a single focus in the head. Thus, therapy with octreotide LAR was initiated. The patient died four months later due to disseminated PTC.
In this paper, a patient with asymptomatic previously unknown non-iodine avid cerebellar metastasis of PTC diagnosed by means of scintigraphy using somatostatin analogue Tc-99m-EDDA/HYNIC-TOC is reported.
Somatostatin receptor scintigraphy might be useful in the visualisation of non-iodine avid PTC metastases and demonstrat-ing the expression of somatostatin receptors that are potential therapeutic targets.
甲状腺乳头状癌(PTC)的远处转移灶可能缺乏摄取放射性碘的能力。在这种情况下,生长抑素受体闪烁显像阳性可能有助于显示作为潜在治疗靶点的生长抑素受体的表达。迄今为止,文献中仅报道了少数PTC小脑转移病例。
我们报告一名82岁女性,在初次诊断四年后通过Tc-99m-EDDA/HYNIC-TOC闪烁显像诊断为无症状性PTC小脑转移。她之前接受了全甲状腺切除术和区域淋巴结清扫术,随后进行了三个周期的放射性碘治疗。尽管甲状腺球蛋白持续升高,但治疗后全身扫描未发现特异性放射性碘摄取。Tc-99m-EDDA/HYNIC-TOC闪烁扫描显示肺部、颈部淋巴结有放射性示踪剂摄取增加的病灶,头部有一个病灶。因此,开始使用长效奥曲肽治疗。患者四个月后因PTC播散死亡。
本文报道了一名通过使用生长抑素类似物Tc-99m-EDDA/HYNIC-TOC的闪烁显像诊断为无症状性、先前未知的非碘摄取性PTC小脑转移的患者。
生长抑素受体闪烁显像可能有助于显示非碘摄取性PTC转移灶,并显示作为潜在治疗靶点的生长抑素受体的表达。